Abstract
There is a compelling demand for approved plague vaccines due to the endemicity of Yersinia pestis and its potential for pandemic spread. Whilst substantial progress has been made, we recommend that the global funding and health security systems should work urgently to translate some of the efficacious vaccines reviewed herein to expedite clinical development and to prevent future disastrous plague outbreaks, particularly caused by antimicrobial resistant Y. pestis strains.
Original language | English (US) |
---|---|
Article number | 162 |
Journal | npj Vaccines |
Volume | 9 |
Issue number | 1 |
DOIs | |
State | Published - Dec 2024 |
ASJC Scopus subject areas
- Immunology
- Pharmacology
- Infectious Diseases
- Pharmacology (medical)